September
Recent News

FDA endorses drinking reductions as valid clinical endpoint in Alcohol Use Disorder Trials Researchers Review
September 17, 2025
UNM Distinguished Professor Katie Witkiewitz leads review focused on WHO Risk Drinking Levels
FDA endorses drinking reductions as valid clinical endpoint in Alcohol Use Disorder Trials Researchers Review
September 17, 2025
UNM Distinguished Professor Katie Witkiewitz leads review focused on WHO Risk Drinking Levels
2025 CASAA Research Day 11/4
October 1, 2025
FDA endorses drinking reductions as valid clinical endpoint in Alcohol Use Disorder Trials Researchers Review
September 17, 2025
CASAA director honored with prestigious mentorship award
August 21, 2025
Study begins on digital intervention for opioid-users
July 26, 2025
CASAA awarded funding for a study on community research
April 8, 2025